RxDoctor Payments Data

Graham Hurvitz, MD

Orthopaedic Surgery · Santa Barbara, CANPI 1104858620

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (44.4%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by Lima USA, Inc. at 59.1% of the total. Reporting peaked in 2022 at $26,493 and has fallen 76.0% since, to $6,358 in 2025. Among orthopaedic surgery clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$95,892in general payments, 2019–2025

Across 264 payments — averaging $363.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lima USA, Inc.$57K
  • Limacorporate S.p.a.$19K
  • Medacta USA, Inc.$8K
  • Smith+Nephew$4K
  • Ortho Development Corporation$3K
  • UOC USA Inc$887
  • plus $4K from 27 others
$5,003in ownership & investment interests, 2019–2025

Across 1 payment — averaging $5002.56 each. An ownership or investment interest held by the physician or an immediate family member.

  • Overture Orthopaedics$5K

What the payments were for

  • Consulting fees$42,54044%
  • Speaking & faculty fees$2,0002%
  • Travel & lodging$37,58139%
  • Food & beverage$13,75214%
  • Entertainment$190%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$95,892 in reported general payments places this provider in the 90th percentile of 1,808 orthopaedic surgery providers in California.

See all orthopaedic surgery providers in California →

Medicare billing

Part B allowed, 2024
$490,849
Medicare patients
658
Services billed
7,454

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen188$3,366
Celecoxib125$2,750
Naloxone Hcl18$1,202
Ondansetron OdtOndansetron85$1,043
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen55$717
Tramadol Hcl174$623
Diclofenac Sodium62$552
Doxycycline Hyclate25$310
Gabapentin40$256
Amoxicillin105$253
Methylprednisolone29$238
Cephalexin56$205
Meloxicam34$167
Ibuprofen13$75
Clindamycin Hcl15$32

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Santa Barbara

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →